The changing and dynamic epidemiology of meningococcal disease.

[1]  M. Ramsay,et al.  Prevalence of Serum Bactericidal Antibody to Serogroup C Neisseria meningitidis in England a Decade after Vaccine Introduction , 2012, Clinical and Vaccine Immunology.

[2]  S. Ladhani,et al.  Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009 , 2012, Emerging infectious diseases.

[3]  R. Borrow,et al.  Seroprevalence of Serum Bactericidal Antibodies against Group W135 and Y Meningococci in England in 2009 , 2011, Clinical and Vaccine Immunology.

[4]  R. Arnold,et al.  Effectiveness of a vaccination programme for an epidemic of meningococcal B in New Zealand. , 2011, Vaccine.

[5]  D. Ala'aldeen,et al.  Carriage of Meningococci by University Students, United Kingdom , 2011, Emerging infectious diseases.

[6]  M. G. Gonçalves,et al.  Outbreak of Neisseria meningitidis C in workers at a large food-processing plant in Brazil: challenges of controlling disease spread to the larger community , 2011, Epidemiology and Infection.

[7]  B. Lefebvre,et al.  Effectiveness of Serogroup C Meningococcal Conjugate Vaccine: A 7-Year Follow-up in Quebec, Canada , 2011, The Pediatric infectious disease journal.

[8]  L. Harrison,et al.  Incorporation of Real-Time PCR into Routine Public Health Surveillance of Culture Negative Bacterial Meningitis in São Paulo, Brazil , 2011, PloS one.

[9]  D. Diop,et al.  Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. , 2011, The New England journal of medicine.

[10]  Q. Bassat,et al.  Epidemiology, Molecular Characterization and Antibiotic Resistance of Neisseria meningitidis from Patients ≤15 Years in Manhiça, Rural Mozambique , 2011, PloS one.

[11]  H. Fredlund,et al.  Genetic characterisation of the emerging invasive Neisseria meningitidis serogroup Y in Sweden, 2000 to 2010. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  E. Zell,et al.  Early Estimate of the Effectiveness of Quadrivalent Meningococcal Conjugate Vaccine , 2011, The Pediatric infectious disease journal.

[13]  D. Lennon,et al.  Antibody persistence following MeNZB vaccination of adults and children and response to a fourth dose in toddlers , 2011, Archives of Disease in Childhood.

[14]  A. Vyse,et al.  Meningococcal disease in Asia: an under-recognized public health burden , 2011, Epidemiology and Infection.

[15]  E. Molyneux,et al.  Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi , 2011, Emerging infectious diseases.

[16]  D. Sugerman,et al.  Surveillance for Invasive Meningococcal Disease in Children, US–Mexico Border, 2005–2008 , 2011, Emerging infectious diseases.

[17]  R. Gasparini,et al.  Meningococcal glycoconjugate vaccines , 2011, Human vaccines.

[18]  D. Ala'aldeen,et al.  Persistence, Replacement, and Rapid Clonal Expansion of Meningococcal Carriage Isolates in a 2008 University Student Cohort , 2010, Journal of Clinical Microbiology.

[19]  Andrew Jardine,et al.  Vaccine preventable diseases in Australia, 2005 to 2007. , 2010, Communicable diseases intelligence quarterly report.

[20]  B. Greenwood,et al.  The epidemiology of meningococcal disease in India , 2010, Tropical medicine & international health : TM & IH.

[21]  J. Rocourt,et al.  Increase in Neisseria meningitidis Serogroup W135, Niger, 2010 , 2010, Emerging infectious diseases.

[22]  E. Bingen,et al.  Association of Meningococcal Phenotypes and Genotypes With Clinical Characteristics and Mortality of Meningitis in Children , 2010, The Pediatric infectious disease journal.

[23]  N. Govender,et al.  Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa , 2010, AIDS.

[24]  W. Hitchcock,et al.  Epidemiology and Meningococcal Serogroup Distribution in the United States , 2010, Clinical pediatrics.

[25]  C. Boog,et al.  The Structure of Neisseria meningitidis Lipid A Determines Outcome in Experimental Meningococcal Disease , 2010, Infection and Immunity.

[26]  L. Harrison,et al.  Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era--United States, 2000-2005. , 2010, The Journal of infectious diseases.

[27]  M. A. Sáfadi,et al.  Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention , 2010, Neurological research.

[28]  N. Andrews,et al.  Updated Postlicensure Surveillance of the Meningococcal C Conjugate Vaccine in England and Wales: Effectiveness, Validation of Serological Correlates of Protection, and Modeling Predictions of the Duration of Herd Immunity , 2010, Clinical and Vaccine Immunology.

[29]  D. Granoff.  Review of meningococcal group B vaccines. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[30]  W. Schaffner,et al.  Changes in Neisseria meningitidis disease epidemiology in the United States, 1998-2007: implications for prevention of meningococcal disease. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[31]  N. Wood,et al.  MODERN TRENDS IN MORTALITY FROM MENINGOCOCCAL DISEASE IN AUSTRALIA , 2009, The Pediatric infectious disease journal.

[32]  A. Wilder-Smith,et al.  Emergence and disappearance of W135 meningococcal disease , 2009, Epidemiology and Infection.

[33]  Lee H Harrison,et al.  Global epidemiology of meningococcal disease. , 2009, Vaccine.

[34]  N. Ravenscroft,et al.  Epidemic meningitis due to Group A Neisseria meningitidis in the African meningitis belt: a persistent problem with an imminent solution. , 2009, Vaccine.

[35]  J. Vázquez,et al.  W135 Invasive Meningococcal Strains Spreading in South America: Significant Increase in Incidence Rate in Argentina , 2009, Journal of Clinical Microbiology.

[36]  T. Ahmed,et al.  Increasing isolations of Neisseria meningitides serogroup A from blood and cerebrospinal fluid in Dhaka, Bangladesh, 1999-2006. , 2009, The American journal of tropical medicine and hygiene.

[37]  R. Breiman,et al.  Epidemiology and risk factors for serogroup X meningococcal meningitis during an outbreak in western Kenya, 2005-2006. , 2009, The American journal of tropical medicine and hygiene.

[38]  A. van der Ende,et al.  Naturally Occurring Lipid A Mutants in Neisseria meningitidis from Patients with Invasive Meningococcal Disease Are Associated with Reduced Coagulopathy , 2009, PLoS pathogens.

[39]  D. Fisman,et al.  Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. , 2009, Vaccine.

[40]  Q. Bassat,et al.  Surveillance of acute bacterial meningitis among children admitted to a district hospital in rural Mozambique. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[41]  S. Halperin,et al.  The Impact of Childhood Meningococcal Serogroup C Conjugate Vaccine Programs in Canada , 2009, The Pediatric infectious disease journal.

[42]  Australian Meningococcal,et al.  Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended. , 2009 .

[43]  X. Beristain,et al.  B:2a:P1.5 Meningococcal Strains Likely Arisen from Capsular Switching Event Still Spreading in Spain , 2008, Journal of Clinical Microbiology.

[44]  M. Capoor,et al.  Outbreak of meningococcal disease in and around New Delhi, India, 2005–2006: a report from a tertiary care hospital , 2008, Epidemiology and Infection.

[45]  C. I. Agudelo,et al.  Serogroup Y Meningococcal Disease, Colombia , 2008, Emerging infectious diseases.

[46]  D. Ye,et al.  Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei city, China , 2008, Postgraduate Medical Journal.

[47]  S. Schrag,et al.  Emergence of endemic serogroup W135 meningococcal disease associated with a high mortality rate in South Africa. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  A. Parkinson,et al.  International Circumpolar Surveillance, An Arctic Network for the Surveillance of Infectious Diseases , 2008, Emerging infectious diseases.

[49]  H. Peltola,et al.  Acute childhood bacterial meningitis in Luanda, Angola , 2008, Scandinavian journal of infectious diseases.

[50]  A. Manirakiza,et al.  Acute bacterial meningitis at the 'Complexe Pédiatrique' of Bangui, Central African Republic. , 2007, Journal of tropical pediatrics.

[51]  R. Arnold,et al.  A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. , 2007, American journal of epidemiology.

[52]  I. Aaberge,et al.  Immunogenicity and safety of a strain-specific MenB OMV vaccine delivered to under 5-year olds in New Zealand. , 2007, Vaccine.

[53]  S. Tyler,et al.  Genetic and Antigenic Analysis of Invasive Serogroup Y Neisseria meningitidis Isolates Collected from 1999 to 2003 in Canada , 2007, Journal of Clinical Microbiology.

[54]  R. Hajjeh,et al.  The epidemiology of pneumococcal, meningococcal, and Haemophilus disease in the Middle East and North Africa (MENA) region--current status and needs. , 2007, Vaccine.

[55]  M. Ramsay,et al.  No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales. , 2006, The Lancet. Infectious diseases.

[56]  P. De Wals,et al.  Invasive Meningococcal Disease in Québec, Canada, Due to an Emerging Clone of ST-269 Serogroup B Meningococci with Serotype Antigen 17 and Serosubtype Antigen P1.19 (B:17:P1.19) , 2006, Journal of Clinical Microbiology.

[57]  M. Gorla,et al.  Phenotypic characterization of Neisseria meningitidis strains isolated from invasive disease in Brazil from 1990 to 2001. , 2006, Journal of medical microbiology.

[58]  H. D. de Melker,et al.  PROTECTION FROM ROUTINE VACCINATION AT THE AGE OF 14 MONTHS WITH MENINGOCOCCAL SEROGROUP C CONJUGATE VACCINE IN THE NETHERLANDS , 2006, The Pediatric infectious disease journal.

[59]  R. Barata,et al.  A doença meningocócica em São Paulo, Brasil, no século XX: características epidemiológicas , 2005 .

[60]  J. C. de Moraes,et al.  [Meningococcal disease in São Paulo, Brazil, in the 20th century: epidemiological characteristics]. , 2005, Cadernos de saude publica.

[61]  W John Edmunds,et al.  Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. , 2005, American journal of epidemiology.

[62]  F. Mahoney,et al.  The changing epidemiology of meningococcal meningitis after introduction of bivalent A/C polysaccharide vaccine into school-based vaccination programs in Egypt. , 2005, Vaccine.

[63]  K. Mulholland,et al.  MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain. , 2005, Vaccine.

[64]  I. Rubio,et al.  Control de un brote epidémico de enfermedad meningocócica por N. meningitidis serogrupo B , 2004 .

[65]  Squires Sg,et al.  Enhanced surveillance of invasive meningococcal disease in Canada: 1 January, 2002, through 31 December, 2003. , 2004, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[66]  J. T. Koama,et al.  Chronicle of an outbreak foretold: meningococcal meningitis W135 in Burkina Faso. , 2002, The Lancet. Infectious diseases.

[67]  R. Tsang,et al.  Distribution of serogroups of Neisseria meningitidis and antigenic characterization of serogroup Y meningococci in Canada, January 1, 1999 to June 30, 2001. , 2002, The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses.

[68]  T. Popović,et al.  Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex. , 2002, The Journal of infectious diseases.

[69]  D. Scheifele,et al.  Meningococcal disease and vaccination in North America , 2001, Journal of paediatrics and child health.

[70]  A. Baly,et al.  The epidemiological impact of antimeningococcal B vaccination in Cuba. , 1999, Memorias do Instituto Oswaldo Cruz.

[71]  M. Baker,et al.  New Zealand epidemic of meningococcal disease identified by a strain with phenotype B:4:P1.4. , 1998, The Journal of infectious diseases.

[72]  D. Kertesz,et al.  Surveillance of invasive meningococcal disease in Canada, 1995-1996. , 1997, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[73]  J. Hanna,et al.  Epidemic meningococcal meningitis in central Australia, 1987–1991 , 1993, The Medical journal of Australia.

[74]  X. Hu.  [Study on periodically prevalent feature for epidemic cerebrospinal meningitis in China]. , 1991, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[75]  Varughese Pv.  Meningococcal disease in Canada: surveillance summary to 1987. , 1989 .

[76]  B. Greenwood,et al.  GROUP-C MENINGOCOCCAL MENINGITIS IN THE NORTHERN SAVANNA OF AFRICA , 1975, The Lancet.

[77]  E. Holten.  [The epidemiology of meningococcal disease]. , 1972, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke.

[78]  Copeman Pw,et al.  PERIODIC BREATHING OF PREMATURE INFANTS. , 1964 .

[79]  PurushottamT. Patel.  Cerebro-Spinal Fever in Bombay. A Study of 170 Consecutive Cases during the Years 1921-24. , 1926 .

[80]  L. Harrison,et al.  21 – Meningococcal vaccines , 2013 .

[81]  S. Halperin,et al.  Profile of serogroup Y meningococcal infections in Canada: Implications for vaccine selection. , 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[82]  IMPACT after 17 years: Lessons learned about successful networking. , 2009, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[83]  Diana R. Martin.  The Epidemiology of Meningococcal Disease in New Zealand in 2005 , 2006 .

[84]  Julia Fox-Rushby,et al.  Vaccine-preventable Diseases , 2006 .

[85]  C. Hart,et al.  Meningococcal Disease , 1974, Nursing standard (Royal College of Nursing (Great Britain) : 1987).

[86]  J. Hughes,et al.  EPIDEMIOLOGIC FEATURES OF MENINGOCOCCAL DISEASE , 2001 .

[87]  B. Sheff,et al.  Neisseria meningitidis , 1999, Nursing.

[88]  P. Varughese.  Meningococcal disease in Canada: surveillance summary to 1987. , 1989, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[89]  C. Broome,et al.  Epidemic group C meningococcal meningitis in Upper Volta, 1979. , 1983, Bulletin of the World Health Organization.

[90]  J. Roux,et al.  Etude d'une épidémie de méningococcie au Viet Nam (provinces du sud)] , 1981 .

[91]  J. Roux,et al.  [An epidemic of meningococcal infection in Vietnam (southern provinces)]. , 1981, Bulletin of the World Health Organization.

[92]  A. el-Akkad.  Epidemiology of cerebrospinal meningitis in Egypt during the last 50 years. , 1969, The Journal of the Egyptian Public Health Association.

[93]  el-Akkad Am.  Epidemiology of cerebrospinal meningitis in Egypt during the last 50 years. , 1969 .